13th BIC International Conference
The BIC International Conference is traditionally addressed to a relatively narrow selection of medical specialties since it is meant to feature only the most novel advances of basic science and clinical research in haemophilia, rare inherited coagulation disorders, von Willebrand factor and von Willebrand disease, gene therapy, the thrombotic microangiopathies and, of course, factor VIII inhibitors.
As one of the leading events for experts in hemophilia, von Willebrand disease, gene therapy, and thrombotic microangiopathies, the BIC Conference offers a unique opportunity to engage in cutting-edge scientific discussions and connect with leading professionals in the field.